ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
The Predictive Value of the Rotational Thromboelastometry for Bleeding Risk in Patients With Child-Pugh Class C Cirrhosis.
Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rotational Thromboelastometry and Bleeding Risk in Child-Pugh C Cirrhosis: Methodological Considerations.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/HemostasisArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectivePatients with cirrhosis are in a fragile state of rebalanced hemostasis and are at risk of bleeding and thrombotic complications. Conventional coagulation tests such as PT, APTT, and fibrinogen often fail to accurately predict bleeding risk in patients with advanced cirrhosis. We aimed to investigate the role of Rotational Thromboelastometry (ROTEM) in predicting bleeding risk due to coagulopathy in patients with decompensated cirrhosis.MethodsWe carried out a retrospective analysis of patients diagnosed with Child-Pugh class C cirrhosis. We conducted ROTEM tests on each patient and observed the results to record any instances of bleeding. To explore the relationship with bleeding incidents, we performed both univariate and multivariate logistic regression analyses.ResultsAmong the 124 patients diagnosed with Child-Pugh C cirrhosis, most were between 40 and 61 years of age. Overall, 59.7% of patients did not experience bleeding events. All ROTEM parameters (INTEM, EXTEM and FIBTEM) associated with clot amplitude, such as A5 and maximum clot firmness (MCF), showed significant differences between patients who experienced bleeding and those who did not (p < 0.05), whereas the clotting time parameters remained unchanged. Multivariate logistic regression analysis revealed that an MCF EXTEM greater than 45 mm was independently associated with a lower risk of bleeding.ConclusionROTEM parameters that indicate clot firmness, especially MCF EXTEM, are associated with bleeding risk in patients with Child-Pugh class C cirrhosis. Viscoelastic testing can be useful in identifying patients with a low bleeding risk and offers a more thorough evaluation of hemostasis than traditional coagulation tests.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.